Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Role of Clinical Pharmacology Guidances and Policies in Enhancing Drug Development
Session Chair(s)

Anuradha Ramamoorthy, PharmD, PhD
- Policy Lead, OCP, OTS, CDER
- FDA, United States
Clinical pharmacology informs dose selection, dose optimization, and therapeutic individualization. Effective clinical pharmacology guidances and policies support an efficient drug development process and consistent regulatory evaluation.
Learning Objective : Describe the value of clinical pharmacology guidances and policies in drug development;Recognize the lifecycle approach supporting the development and implementation of clinical pharmacology guidances; Discuss the role of regulatory research and other stakeholder input in the development of clinical pharmacology guidances and policies.
Speaker(s)
Role of Guidance and Policy in Advancing Clinical Pharmacology
Rajanikanth Madabushi, PhD
- Associated Director for Guidance and Scientific Policy, OCP, OTS, CDER
- FDA, United States

Advancing Clinical Pharmacology Through Regulatory Policy and Partnership
Samantha Roberts, PhD
- Group Director, US Regulatory Policy
- Genentech, A Member of the Roche Group, United States
Academia Update
Kathleen M. Giacomini, PhD
- Professor, Bioengineering and Therapeutic Sciences; CERSI Co-Director
- University of California San Francisco, United States

Panelist
David Boulton, PhD
- Clinical Pharmacology and Quantitative Pharmacology Head of Post Marketing
- AstraZeneca, United States